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The cure rate for late stage epithelial ovarian cancer (EOC) has not significantly improved for 
patients over the past 20 years. The current standard of care is aggressive surgery followed by 
platinum/paclitaxel chemotherapy. However, approximately 25% of patients will develop platinum 
resistant cancer within 6 months and the overall 5-year survival is only 31%.  Therefore, new and 
more effective treatment modalities that target additional molecular pathways are urgently needed. 
The functional and mechanistic studies presented here clearly support that the FOXM1 network is 
an important target for developing new EOC therapeutics. This network includes the newly 
identified LPA as an up-stream regulator of FOXM1 and down-stream targets. Tumor cell specific 
targeting may be necessary and tumor and/or tumor-host interactions generating secreted factors, 
such as amphiregulin (AREG) and/or VEGF, may be used as follow-up factors to monitor 
treatment and disease progression. 
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